JP2007504099A - 丹参、その抽出物および組成物を用いたアスピリン耐性の治療 - Google Patents

丹参、その抽出物および組成物を用いたアスピリン耐性の治療 Download PDF

Info

Publication number
JP2007504099A
JP2007504099A JP2006524202A JP2006524202A JP2007504099A JP 2007504099 A JP2007504099 A JP 2007504099A JP 2006524202 A JP2006524202 A JP 2006524202A JP 2006524202 A JP2006524202 A JP 2006524202A JP 2007504099 A JP2007504099 A JP 2007504099A
Authority
JP
Japan
Prior art keywords
rsm
filtrate
aspirin
ethanol
pills
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006524202A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007504099A5 (enExample
Inventor
▲いぇん▼希軍
呉▲ない▼峰
叶正良
李旭
郭治▲しん▼
趙▲な▼
Original Assignee
天津天士力制薬股▲ふん▼有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34621020&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2007504099(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CNB031552757A external-priority patent/CN100391486C/zh
Priority claimed from CNB2004100198381A external-priority patent/CN100411641C/zh
Application filed by 天津天士力制薬股▲ふん▼有限公司 filed Critical 天津天士力制薬股▲ふん▼有限公司
Publication of JP2007504099A publication Critical patent/JP2007504099A/ja
Publication of JP2007504099A5 publication Critical patent/JP2007504099A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2006524202A 2003-08-28 2004-08-26 丹参、その抽出物および組成物を用いたアスピリン耐性の治療 Pending JP2007504099A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNB031552757A CN100391486C (zh) 2003-08-28 2003-08-28 复方丹参滴丸在制备治疗阿司匹林抵抗性心血管疾病的药物中的应用
CNB2004100198381A CN100411641C (zh) 2004-06-30 2004-06-30 一种滴丸剂在制备治疗阿司匹林抵抗药物中的应用
PCT/CN2004/000989 WO2005049058A1 (en) 2003-08-28 2004-08-26 Radix salviae miltiorrhizae, extract and composition thereof for the treatment of the aspirin resistance diseases

Publications (2)

Publication Number Publication Date
JP2007504099A true JP2007504099A (ja) 2007-03-01
JP2007504099A5 JP2007504099A5 (enExample) 2011-05-12

Family

ID=34621020

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006524202A Pending JP2007504099A (ja) 2003-08-28 2004-08-26 丹参、その抽出物および組成物を用いたアスピリン耐性の治療

Country Status (13)

Country Link
US (2) US20070071837A1 (enExample)
EP (1) EP1658879B1 (enExample)
JP (1) JP2007504099A (enExample)
KR (1) KR101210405B1 (enExample)
AU (1) AU2004290484B8 (enExample)
CA (1) CA2537300C (enExample)
DK (1) DK1658879T3 (enExample)
EA (1) EA010910B1 (enExample)
ES (1) ES2405599T3 (enExample)
MY (1) MY143282A (enExample)
NO (1) NO335203B1 (enExample)
PT (1) PT1658879E (enExample)
WO (1) WO2005049058A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012522022A (ja) * 2009-03-30 2012-09-20 タスリー・ファーマシューティカル・グループ・カンパニー・リミテッド 新規サルビアノール酸化合物ｌ、その調製方法及び使用
JP2013520450A (ja) * 2010-02-23 2013-06-06 テースリー ファーマシューティカル グループ カンパニー リミテッド 複方タンジン滴丸剤のカプセル剤
JP2015526511A (ja) * 2012-08-29 2015-09-10 バイオトロピクス マレーシア ベルハッドＢｉｏｔｒｏｐｉｃｓ Ｍａｌａｙｓｉａ Ｂｅｒｈａｄ 認知及び美容を目的とする組成物

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2384878T3 (es) * 2003-11-07 2012-07-13 Basf Beauty Care Solutions S.A.S. Uso cosmético de un extracto de la fruta de Schisandra chinensis
MY147497A (en) * 2005-10-12 2012-12-14 Government Of Malaysia As Represented By The Ministry Of Science Technology And Innovation Malaysia Process for preparation of labisia pumila extract
GB2439046B (en) * 2006-06-16 2010-12-08 Phynova Ltd Antiviral product
US20120148685A1 (en) * 2009-06-10 2012-06-14 Engergy4Life AG Methods and compositions for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome and related disorders
CN103099896B (zh) * 2013-01-06 2014-10-01 车艳艳 治疗心脑血管疾病的药茶
CN103169777B (zh) * 2013-02-07 2014-09-10 江苏七○七天然制药有限公司 一种治疗心血管疾病的中药胶囊

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002058625A2 (en) * 2000-12-22 2002-08-01 Tianjin Tasly Pharmaceutical Co., Ltd., China Herbal composition for angina pectoris, method to prepare same and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104286D0 (en) * 1991-02-28 1991-04-17 Phytopharm Ltd Pharmaceutical compositions for the treatment of skin disorders
AU6224200A (en) * 1999-10-25 2001-05-08 Colorado Coagulation Consultants Thromboxane B2 metabolite and methods for regulating aspirin-related platelet action
JP2001354579A (ja) * 2000-06-15 2001-12-25 Lion Corp 抗炎症化粧料
US8486464B2 (en) * 2000-12-22 2013-07-16 Tasly Pharmaceutical Group Co. Ltd. Herbal composition for angina pectoris, method to prepare same and uses thereof
US20050037094A1 (en) * 2003-07-31 2005-02-17 Xijun Yan Composition for heart disease, its active ingredients, method to prepare same and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002058625A2 (en) * 2000-12-22 2002-08-01 Tianjin Tasly Pharmaceutical Co., Ltd., China Herbal composition for angina pectoris, method to prepare same and uses thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012522022A (ja) * 2009-03-30 2012-09-20 タスリー・ファーマシューティカル・グループ・カンパニー・リミテッド 新規サルビアノール酸化合物ｌ、その調製方法及び使用
JP2013520450A (ja) * 2010-02-23 2013-06-06 テースリー ファーマシューティカル グループ カンパニー リミテッド 複方タンジン滴丸剤のカプセル剤
US9205123B2 (en) 2010-02-23 2015-12-08 Tasly Pharmaceutical Group Co., Ltd. Capsule of compound danshen dripping pills
JP2015526511A (ja) * 2012-08-29 2015-09-10 バイオトロピクス マレーシア ベルハッドＢｉｏｔｒｏｐｉｃｓ Ｍａｌａｙｓｉａ Ｂｅｒｈａｄ 認知及び美容を目的とする組成物

Also Published As

Publication number Publication date
EA010910B1 (ru) 2008-12-30
EP1658879A1 (en) 2006-05-24
AU2004290484B2 (en) 2010-03-25
HK1092090A1 (en) 2007-02-02
US20070071837A1 (en) 2007-03-29
EP1658879A4 (en) 2008-11-26
EA200600471A1 (ru) 2006-08-25
WO2005049058A8 (en) 2005-08-11
AU2004290484B8 (en) 2010-05-13
KR20070017944A (ko) 2007-02-13
AU2004290484A1 (en) 2005-06-02
DK1658879T3 (da) 2013-05-13
NO20060832L (no) 2006-02-21
MY143282A (en) 2011-04-15
EP1658879B1 (en) 2013-02-20
NO335203B1 (no) 2014-10-20
CA2537300C (en) 2013-07-30
PT1658879E (pt) 2013-04-08
CA2537300A1 (en) 2005-06-02
WO2005049058A1 (en) 2005-06-02
US20080305189A1 (en) 2008-12-11
KR101210405B1 (ko) 2012-12-10
ES2405599T3 (es) 2013-05-31

Similar Documents

Publication Publication Date Title
JP2007505936A (ja) 循環器疾患および脳血管疾患の処置のための薬学的組成物
US20080305189A1 (en) Treatment of aspirin resistance with radix salviae miltiorrhizae, its extract and composition
KR100980819B1 (ko) 복합생약 추출물을 유효성분으로 함유하는 조성물 및 이의제조방법
RS20080536A (sr) Kompozicija koja sadrži bar jedan viši alifatični alkohol i ekstrakt biljke griffonia simplicifolia
KR101456937B1 (ko) 천연물 추출물로 구성된 비만의 억제 및 치료용 조성물
JP2007504099A5 (enExample)
Musthaba et al. Patented herbal formulations and their therapeutic applications
US20160136218A1 (en) Molecular and Herbal Combinations for Disease Therapy
CN103830436A (zh) 治疗高血压的中药组合物及其制备方法
TWI391142B (zh) 丹參、其提取物及組成物對阿斯匹靈抵抗的治療應用
CN103055122A (zh) 预防冠脉支架植入术后再狭窄的药物及其制备方法
CN100411641C (zh) 一种滴丸剂在制备治疗阿司匹林抵抗药物中的应用
CN103830495A (zh) 一种治疗糖尿病性视网膜病变所致眼底出血的中药组合物及其制备方法
CN103505636A (zh) 治疗冠心病心绞痛的养心颗粒
ZA200601412B (en) Treatment of aspirin resistance with radix salviae miltiorrhizae, its extract and composition
JPH06172196A (ja) 血液粘性低下剤及びそれを含む組成物
CN103356731A (zh) 含有杜仲提取物与三七总皂苷的血塞通片及其应用
KR20120113170A (ko) 치주질환의 예방 및 개선용 조성물
CN103055160A (zh) 一种治疗血瘀型疼痛中药组合物及其制备方法
CN107661422B (zh) 一种防治冠心病的中药组合物及其制备方法
HK1092090B (en) Radix salviae miltiorrhizae, extract and composition thereof for the treatment of the aspirin resistance diseases
CN105596420A (zh) 一种丹七组合物的应用及制备方法
CN117695365A (zh) 一种用于治疗心脑血管疾病的中药组合物及其制备方法
CN115054661A (zh) 一种降压中药组合物及其制备方法
CN101647911B (zh) 治疗头痛的中药组合物和制剂及其制备方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070814

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101026

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110124

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110131

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110225

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110304

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110315

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110323

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20110323

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110323

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20111108